MIR1-1HG-AS1

Across TCGA pan-cancer cohorts, MIR1-1HG-AS1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated MIR1-1HG-AS1 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR1-1HG-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR1-1HG-AS1 expression acts as an unfavorable survival marker.

BRCA, COAD, and UCEC are the cancer types where MIR1-1HG-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.146	0.924	<.001	36	view →
COAD	OS	Median	III,IV	0.239	0.699	.002	19	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LIHC	OS	Median	All	0.105	0.774	.002	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR1-1HG-AS1–BRCA (OS)

Open the BRCA breakdown →